Drug Trial Radar · NCT01872715
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Last checked: Nov 20, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Mar 2013
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Jun 7, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.
Conditions
- Papulopustular Rosacea
Interventions
OraceaDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rosacea Score on the Visual Analog ScaleTime frame: Baseline, Weeks 2, 6, and 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stephens & Associates Dallas Research Center
Carrollton, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.